Grant: Doctoral Research Award - PA: Digestive Health (SHOPP)
McGill University
$72,000.00
Identification of Genetic Loci Controlling Susceptibility to Colitis-Associated Colorectal Cancer in Mice
FY 2010-11
Summary
Colorectal cancer (CRC) is the second leading cause of cancer related deaths in Canada. My current research involves the use of mouse models to identify and characterize predisposing CRC risk factors in the form of low penetrance tumor susceptibility genes. The premise of my research is that a better understanding of these genes will help to identify those at risk of developing CRC and assist researchers in understanding the cellular and molecular mechanisms mediating CRC development.
The mouse model used in my research mimics colitis-associated (CA)-CRC in humans and allows me to study these gene effects independently of diet and lifestyle risk factors, which often complicate human studies. My initial studies have identified two genetic regions (loci) that interact with each other to regulate susceptibility to CA-CRC in A/J (susceptible) and B6 (resistant) mice. My ongoing studies are designed to define the specific gene effects and mechanisms underling this differential susceptibility. This will involve further testing of different mouse strains and subsequent gene sequencing to identify the causative mutations. To understand the mechanism underlying increased tumor development in A/J mice I will first focus on identifying differences in the immune cells and inflammatory mediators released into the colon at various experimental time points. The long-term goal of my project will involve validation of these loci in human CRC association studies and tumor samples. Multi-gene interactions associated with CRC susceptibility have yet to be identified in humans and therefore this model provides a starting point to search for such interactions.
Recently, inflammation has been referred to as the seventh hallmark of cancer, suggesting that the underling genes and mechanisms associated with differential CA-CRC in this model may have relevance to other cancers. Therefore, it is hoped that this knowledge will assist in the detection and treatment of CRC and other cancers.
Department
Program
Doctoral Research Award - PA: Digestive Health (SHOPP)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
218761
Name
Van Der Kraak Lauren A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Digestive Health Foundation
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification of Genetic Loci Controlling Susceptibility to Colitis-Associated Colorectal Cancer in Mice
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$72,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Digestive Health (SHOPP)
Keyworddelim
Azoxymethane; Colitis-Associated Colon Cancer; Dextran Sulfate Sodium; Familial Colon Cancer; Gene Mapping; Inflammatory Bowel Disease; Mouse Models
Abstract
Colorectal cancer (CRC) is the second leading cause of cancer related deaths in Canada. My current research involves the use of mouse models to identify and characterize predisposing CRC risk factors in the form of low penetrance tumor susceptibility genes. The premise of my research is that a better understanding of these genes will help to identify those at risk of developing CRC and assist researchers in understanding the cellular and molecular mechanisms mediating CRC development.
The mouse model used in my research mimics colitis-associated (CA)-CRC in humans and allows me to study these gene effects independently of diet and lifestyle risk factors, which often complicate human studies. My initial studies have identified two genetic regions (loci) that interact with each other to regulate susceptibility to CA-CRC in A/J (susceptible) and B6 (resistant) mice. My ongoing studies are designed to define the specific gene effects and mechanisms underling this differential susceptibility. This will involve further testing of different mouse strains and subsequent gene sequencing to identify the causative mutations. To understand the mechanism underlying increased tumor development in A/J mice I will first focus on identifying differences in the immune cells and inflammatory mediators released into the colon at various experimental time points. The long-term goal of my project will involve validation of these loci in human CRC association studies and tumor samples. Multi-gene interactions associated with CRC susceptibility have yet to be identified in humans and therefore this model provides a starting point to search for such interactions.
Recently, inflammation has been referred to as the seventh hallmark of cancer, suggesting that the underling genes and mechanisms associated with differential CA-CRC in this model may have relevance to other cancers. Therefore, it is hoped that this knowledge will assist in the detection and treatment of CRC and other cancers.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Van Der Kraak, Lauren A
Approvedterm
3 ans 0 mois
Cihrcontribution2
SPIR~ $72,000~ $0~